Low Vitamin D Symptoms: What Could Be Causing It and What to Do Next

What Low Vitamin D Actually Feels Like

Vitamin D deficiency produces a cluster of symptoms that mimic half a dozen other conditions, which is why it gets missed so often. Fatigue is the most common complaint, followed by dull, diffuse bone tenderness (especially over the sternum, tibia, and lower back), proximal muscle weakness that makes stair-climbing or rising from a chair unexpectedly hard, and low or depressed mood.

These symptoms appear because vitamin D is a secosteroid hormone, not simply a micronutrient. Every cell in the body carries a vitamin D receptor (VDR), and VDR signaling controls calcium absorption, muscle fiber contractility, immune modulation, and neurotransmitter synthesis. When serum 25(OH)D drops below roughly 20 ng/mL, those processes degrade simultaneously.

Musculoskeletal Symptoms

Bone pain from vitamin D deficiency is the cardinal feature of osteomalacia, the adult-onset softening of bone matrix. A 2010 systematic review in the BMJ found that serum 25(OH)D below 20 ng/mL was associated with significantly higher rates of musculoskeletal pain and bone fragility compared with replete controls [1]. Tenderness on pressing the shin or sternum is a quick bedside sign clinicians use to flag possible osteomalacia before labs return.

Proximal myopathy, meaning weakness of the shoulder girdle and hip flexors, is less widely recognized but well documented. Patients often describe difficulty lifting their arms overhead or getting up from a low seat. A systematic review published in JAMA Internal Medicine (2011) found that vitamin D supplementation reduced fall risk by roughly 19% in community-dwelling older adults, suggesting that myopathy is both common and at least partially reversible [2].

Fatigue and Neuropsychiatric Symptoms

Fatigue linked to vitamin D deficiency is non-specific but real. A randomized controlled trial of 120 fatigued adults without other diagnoses found that cholecalciferol 50,000 IU per week for 8 weeks significantly reduced fatigue scores compared to placebo (P<0.001) [3]. Depression and anxiety are also associated, though causation is harder to establish. The Endocrine Society's 2011 Clinical Practice Guideline states: "Vitamin D deficiency has been associated with depression, cognitive impairment, and increased risk of schizophrenia" [4].

Less Obvious Presentations

Frequent infections, especially upper-respiratory illnesses, can indicate deficiency. VDR activation in macrophages and T-cells is required to mount an effective innate immune response. Hair thinning, impaired wound healing, and nonspecific brain fog are reported by patients but have weaker trial-level evidence behind them. They are worth mentioning to a clinician rather than attributing entirely to vitamin D without workup.

The Most Common Causes of Low Vitamin D

Most people with low vitamin D levels share one or more of four root causes: not enough skin-to-sun contact, not enough dietary intake, impaired absorption through the gut, or accelerated breakdown by medications or metabolic disease.

Insufficient Sun Exposure

Skin synthesizes vitamin D3 from UVB radiation in the 290 to 315 nm range. People who live above 37° north latitude (roughly the line from San Francisco to Richmond, Virginia) get essentially zero UVB synthesis from November through February, regardless of time spent outdoors. Daily sunscreen use (SPF 30 blocks roughly 95 to 98% of UVB), full-body clothing, and predominantly indoor work all reduce synthesis further. A study in the American Journal of Clinical Nutrition showed that adults with outdoor occupations had 25(OH)D levels averaging 22 ng/mL higher than matched office workers in the same region [5].

Dietary Insufficiency

Very few foods naturally contain vitamin D. Fatty fish (salmon, mackerel, sardines), egg yolks, and beef liver are the primary natural sources; fortified milk, orange juice, and cereals are the main dietary vehicles in the United States. A person who avoids fortified foods and fatty fish, follows a strict plant-based diet, or has food insecurity is at high risk. The average American diet provides only about 200 to 300 IU per day, well below the 600 to 800 IU Recommended Dietary Allowance for adults under 70 [6].

Malabsorption Syndromes

Vitamin D is fat-soluble, meaning it requires bile salts and functioning small bowel mucosa to be absorbed. Conditions that impair fat absorption reliably drive vitamin D levels down:

• Celiac disease (untreated)
• Crohn's disease involving the proximal small bowel
• Bariatric surgery, especially Roux-en-Y gastric bypass
• Cystic fibrosis
• Short bowel syndrome
• Chronic pancreatitis

A prospective study of 50 post-bariatric patients found that 50% had 25(OH)D below 20 ng/mL at one-year follow-up despite standard supplementation protocols, underscoring how aggressively this population needs monitoring [7].

Medications That Lower Vitamin D

Several widely prescribed drugs accelerate the hepatic catabolism of 25(OH)D via cytochrome P450 enzyme induction or otherwise interfere with vitamin D metabolism:

• Rifampin (tuberculosis treatment): induces CYP24A1, the enzyme that degrades active vitamin D
• Phenytoin, carbamazepine, phenobarbital: anticonvulsants that induce CYP3A4 and CYP24A1
• Glucocorticoids (prednisone, dexamethasone): reduce intestinal calcium and vitamin D absorption and increase renal excretion
• Cholestyramine: binds bile acids and reduces fat-soluble vitamin absorption
• Orlistat: blocks intestinal lipase, reducing fat and fat-soluble vitamin absorption

Patients on any of these agents long-term should have 25(OH)D monitored at least annually.

Medical Conditions That Impair Conversion

Vitamin D from the skin or diet requires two hydroxylation steps to become active. The liver converts D3 to 25(OH)D; the kidneys then convert 25(OH)D to 1,25-dihydroxyvitamin D (calcitriol), the biologically active form. Chronic kidney disease (CKD) stages 3 to 5 impairs that second step. Liver cirrhosis impairs the first. Both result in functional vitamin D deficiency even when dietary intake is adequate. Hyperparathyroidism, sarcoidosis, and granulomatous diseases can dysregulate the conversion axis in different directions and require specialist management rather than straightforward supplementation.

Obesity and Body Composition

Adipose tissue sequesters vitamin D. Because 25(OH)D is lipophilic, larger fat mass dilutes circulating vitamin D into a bigger volume. The result: people with a body mass index above 30 kg/m² consistently show 25(OH)D levels about 10 to 20% lower than lean adults at the same dietary intake and sun exposure [8]. Weight loss reverses a portion of this effect.

How Vitamin D Deficiency Is Diagnosed

The correct test is serum 25-hydroxyvitamin D (25(OH)D), measured by immunoassay or liquid chromatography-tandem mass spectrometry. Ordering 1,25-dihydroxyvitamin D (calcitriol) is a common error; calcitriol is tightly regulated by parathyroid hormone and may be normal or even elevated in the presence of frank deficiency.

Interpreting Your Result

| 25(OH)D Level | Classification | |---|---| | <12 ng/mL (<30 nmol/L) | Severe deficiency; rickets/osteomalacia risk | | 12 to 19 ng/mL (30 to 49 nmol/L) | Deficiency | | 20 to 29 ng/mL (50 to 74 nmol/L) | Insufficiency | | 30 to 50 ng/mL (75 to 125 nmol/L) | Sufficient for most adults | | >50 ng/mL (>125 nmol/L) | Potential excess; toxicity risk above 150 ng/mL |

The Endocrine Society defines deficiency as 25(OH)D below 20 ng/mL and recommends a target of 40 to 60 ng/mL for patients with conditions driving higher needs [4].

Additional Labs Worth Ordering

When 25(OH)D comes back low, a complete panel should include:

• Calcium and phosphorus: hypocalcemia and hypophosphatemia accompany severe deficiency
• Parathyroid hormone (PTH): secondary hyperparathyroidism (elevated PTH in response to low calcium) is a direct consequence of deficiency and a marker of chronicity
• Alkaline phosphatase: elevated in osteomalacia
• Magnesium: low magnesium impairs PTH secretion and can cause apparent vitamin D resistance

PTH elevation alongside low 25(OH)D is strong evidence that the deficiency is functionally significant, not borderline.

Differential Diagnosis: Other Conditions That Mimic Low Vitamin D Symptoms

Symptoms like fatigue, bone pain, and muscle weakness are not specific to vitamin D deficiency. Getting a 25(OH)D level rules the diagnosis in or out, but clinicians should also consider:

• Hypothyroidism: fatigue, myalgia, depression, and cold intolerance; TSH is the screening test
• Iron-deficiency anemia: fatigue and pallor; serum ferritin and CBC confirm
• Fibromyalgia: diffuse musculoskeletal pain without objective lab abnormality
• Rheumatoid arthritis / inflammatory arthropathy: joint pain with elevated ESR and CRP
• Multiple sclerosis: fatigue and limb weakness in younger adults
• Depression: low mood and fatigue; PHQ-9 screening is appropriate alongside labs
• Hyperparathyroidism: bone pain and fatigue; elevated calcium and PTH distinguish this
• Celiac disease: fatigue, bone pain, AND the cause of secondary vitamin D deficiency; TTG-IgA screening is warranted in patients with GI symptoms

These conditions can also coexist with vitamin D deficiency rather than simply mimicking it.

Evidence-Based Treatment for Low Vitamin D

Treatment depends on severity, cause, and the patient's ability to absorb oral supplements.

Repletion Protocols for Deficiency

The Endocrine Society's 2011 guideline recommends [4]:

• Adults with deficiency (25(OH)D <20 ng/mL): 50,000 IU of ergocalciferol (D2) or cholecalciferol (D3) weekly for 8 weeks, then reassess. If baseline PTH is elevated, extend to 12 weeks.
• Maintenance after repletion: 1,500 to 2,000 IU/day of D3
• Obese patients or malabsorption: require 2 to 3 times the standard dose; daily 6,000 to 10,000 IU may be needed

D3 (cholecalciferol) raises and sustains serum 25(OH)D more effectively than D2 (ergocalciferol) at equivalent doses, based on a head-to-head RCT published in the American Journal of Clinical Nutrition [9].

Monitoring During Treatment

Recheck 25(OH)D six to eight weeks after starting repletion. PTH should normalize once 25(OH)D exceeds 30 to 40 ng/mL. If PTH remains elevated despite adequate 25(OH)D, consider primary hyperparathyroidism or magnesium deficiency.

Toxicity is uncommon with oral supplementation. Vitamin D toxicity (hypercalcemia, nephrolithiasis) generally requires sustained intake above 10,000 IU/day or serum 25(OH)D consistently above 150 ng/mL [4].

Dietary and Lifestyle Measures

Supplementation corrects deficiency faster than dietary change alone, but food-based sources still matter for long-term maintenance:

• Farmed Atlantic salmon (3.5 oz): approximately 450 to 600 IU
• Fortified whole milk (8 oz): approximately 100 to 120 IU
• Fortified orange juice (8 oz): approximately 100 IU
• Two large egg yolks: approximately 80 IU

Sensible sun exposure (10 to 20 minutes of midday sun on arms and legs without sunscreen, 3 to 4 days per week, between April and October at mid-latitudes) contributes another 1,000 to 2,000 IU equivalent per session in fair-skinned adults. Darker skin requires longer exposure to generate the same output [5].

Special Populations

Pregnant and breastfeeding women: the American College of Obstetricians and Gynecologists (ACOG) recommends screening at-risk pregnant patients and supplementing with 1,000 to 2,000 IU/day to maintain 25(OH)D above 20 ng/mL throughout pregnancy [10]. Breast milk contains very little vitamin D; the American Academy of Pediatrics recommends 400 IU/day supplementation for all breastfed infants from the first days of life.

Older adults: absorption efficiency, renal conversion, and skin synthesis all decline with age. Adults over 70 need 800 IU/day per the National Academy of Medicine, though many endocrinologists target 1,500 to 2,000 IU/day for this group given the fall and fracture data.

CKD patients: standard supplementation does not adequately correct active vitamin D deficiency in stage 4 to 5 CKD. These patients often need activated vitamin D analogs (calcitriol 0.25 to 0.5 mcg daily or paricalcitol) prescribed by a nephrologist.

When Low Vitamin D Symptoms Should Prompt Urgent Evaluation

Most vitamin D deficiency is a non-urgent, chronic condition. A few presentations warrant faster workup.

Symptomatic hypocalcemia (tetany, perioral numbness, carpopedal spasm, positive Chvostek or Trousseau sign) alongside low vitamin D needs same-day evaluation and possible IV calcium. This occurs most often post-parathyroidectomy or post-bariatric surgery.

Severe osteomalacia with multiple stress fractures or vertebral compression is an orthopedic emergency requiring imaging and inpatient workup.

A calcium level above 10.5 mg/dL in a patient you suspected to have simple deficiency should trigger workup for primary hyperparathyroidism, malignancy, or granulomatous disease, not empiric vitamin D supplementation.

The HealthRX Clinical Perspective

Our clinical team uses a tiered approach to evaluating patients who present with fatigue, bone pain, or muscle weakness alongside a low 25(OH)D:

Tier 1 (all patients): 25(OH)D, calcium, phosphorus, PTH, magnesium, CBC, TSH, CMP, ferritin. This panel takes one blood draw and rules in or out the most common overlapping diagnoses.

Tier 2 (if PTH elevated or absorption concern exists): Celiac serology (TTG-IgA), albumin, alkaline phosphatase isoforms, urine calcium/creatinine ratio.

Tier 3 (if Tier 1 and 2 are unrevealing and symptoms persist): ESR, CRP, ANA, rheumatology or endocrinology referral.

Starting vitamin D repletion before completing Tier 1 labs is acceptable when deficiency is clinically obvious and the patient is symptomatic. A missed concurrent diagnosis (celiac, hyperparathyroidism) is the main risk of treating empirically without a full panel.

The Endocrine Society guideline specifically states: "We suggest not to use the serum 1,25-dihydroxyvitamin D assay for diagnosing vitamin D deficiency in patients with disorders affecting vitamin D metabolism... And in CKD" [4]. Ordering the wrong test is one of the most common reasons deficiency goes unrecognized for months.

If 25(OH)D normalizes with treatment but symptoms persist, the workup should restart from the differential diagnosis list above. Vitamin D deficiency rarely explains persistent fatigue or pain entirely on its own in a middle-aged adult with multiple comorbidities.